438 related articles for article (PubMed ID: 24887143)
1. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
[TBL] [Abstract][Full Text] [Related]
2. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
[TBL] [Abstract][Full Text] [Related]
3. Decrease in the proportion of CD24
Wang Y; Qin Y; Wang X; Zhang L; Wang J; Xu X; Chen H; Hsu HT; Zhang M
Clin Exp Immunol; 2020 Apr; 200(1):22-32. PubMed ID: 31849037
[TBL] [Abstract][Full Text] [Related]
4. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
[TBL] [Abstract][Full Text] [Related]
5. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.
Blair PA; Noreña LY; Flores-Borja F; Rawlings DJ; Isenberg DA; Ehrenstein MR; Mauri C
Immunity; 2010 Jan; 32(1):129-40. PubMed ID: 20079667
[TBL] [Abstract][Full Text] [Related]
6. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
7. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
[TBL] [Abstract][Full Text] [Related]
8. Increased proportion of a CD38
Ishioka-Takei E; Yoshimoto K; Suzuki K; Nishikawa A; Yasuoka H; Yamaoka K; Takeuchi T
Clin Immunol; 2018 Feb; 187():85-91. PubMed ID: 29061446
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24
Körber N; Pohl L; Weinberger B; Grubeck-Loebenstein B; Wawer A; Knolle PA; Roggendorf H; Protzer U; Bauer T
Front Immunol; 2021; 12():713351. PubMed ID: 34566969
[TBL] [Abstract][Full Text] [Related]
10. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
11. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome.
Jin L; Yu D; Li X; Yu N; Li X; Wang Y; Wang Y
Int J Clin Exp Pathol; 2014; 7(5):1988-96. PubMed ID: 24966908
[TBL] [Abstract][Full Text] [Related]
12. IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren's syndrome.
Lin X; Wang X; Xiao F; Ma K; Liu L; Wang X; Xu D; Wang F; Shi X; Liu D; Zhao Y; Lu L
Cell Mol Immunol; 2019 Dec; 16(12):921-931. PubMed ID: 30948793
[TBL] [Abstract][Full Text] [Related]
13. Chronic obstructive pulmonary disease is characterized by reduced levels and defective suppressive function of regulatory B cells in peripheral blood.
Lin S; Ma Z; Huang Y; Sun Y; Yi H
Mol Immunol; 2022 Jan; 141():87-93. PubMed ID: 34837778
[TBL] [Abstract][Full Text] [Related]
14. Functional implications of regulatory B cells in human IgA nephropathy.
Wang YY; Zhang L; Zhao PW; Ma L; Li C; Zou HB; Jiang YF
Scand J Immunol; 2014 Jan; 79(1):51-60. PubMed ID: 24219615
[TBL] [Abstract][Full Text] [Related]
15. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.
Khoder A; Sarvaria A; Alsuliman A; Chew C; Sekine T; Cooper N; Mielke S; de Lavallade H; Muftuoglu M; Fernandez Curbelo I; Liu E; Muraro PA; Alousi A; Stringaris K; Parmar S; Shah N; Shaim H; Yvon E; Molldrem J; Rouce R; Champlin R; McNiece I; Mauri C; Shpall EJ; Rezvani K
Blood; 2014 Sep; 124(13):2034-45. PubMed ID: 25051962
[TBL] [Abstract][Full Text] [Related]
16. CD19
Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
[TBL] [Abstract][Full Text] [Related]
17. Increasing numbers of CD19 + CD24
Hayashi T; Nakamae H; Takeda S; Nakashima Y; Koh H; Nishimoto M; Okamura H; Nanno S; Makuuchi Y; Kuno M; Nakamae M; Hirose A; Hino M
Int J Hematol; 2021 Nov; 114(5):580-590. PubMed ID: 34309815
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
[TBL] [Abstract][Full Text] [Related]
19. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
[TBL] [Abstract][Full Text] [Related]
20. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
